Contact Suneva Medical
The Company was formed in April 2009 and is backed by Cowen Healthcare Royalty Partners, a global healthcare private equity firm with $500 million in capital under management. Cowen Healthcare's investment strategy is to make long-term investments in unique and promising healthcare products and companies and the firm has a proven track record of success.
Artefill® is our first commercial product and Suneva Medical manufactures, sells and distributes Artefill in the U.S.
Our proprietary platform technology is based on formulations of microsphere-enhanced collagen. Artefill utilizes this technology and is approved for the correction of nasolabial folds, better known as smile lines. The platform also has broad therapeutic applicability in the dermatology, plastic and cosmetic surgery markets and is being studied in acne, traumatic scar correction and non-surgical rhinoplasty.